WFG Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$46K Buy
734
+1
+0.1% +$60 0.01% 717
2017
Q1
$43K Sell
733
-1,363
-65% -$79.7K 0.01% 697
2016
Q4
$117K Sell
2,096
-394
-16% -$22.7K 0.03% 487
2016
Q3
$154K Buy
2,490
+401
+19% +$26.3K 0.04% 426
2016
Q2
$132K Buy
2,089
+4
+0.2% +$252 0.04% 435
2016
Q1
$125K Sell
2,085
-909
-30% -$55.6K 0.04% 427
2015
Q4
$209K Buy
2,994
+97
+3% +$6.88K 0.06% 280
2015
Q3
$192K Buy
2,897
+2
+0.1% +$156 0.06% 302
2015
Q2
$227K Sell
2,895
-246
-8% -$19.1K 0.06% 311
2015
Q1
$240K Sell
3,141
-2,431
-44% -$179K 0.07% 307
2014
Q4
$371K Sell
5,572
-36,526
-87% -$2.43M 0.08% 293
2014
Q3
$2.68M Buy
42,098
+279
+0.7% +$17.2K 0.51% 29
2014
Q2
$2.55M Sell
41,819
-440
-1% -$25.5K 0.48% 34
2014
Q1
$2.39M Buy
42,259
+904
+2% +$51.3K 0.48% 28
2013
Q4
$2.21M Buy
41,355
+27,797
+205% +$1.39M 0.31% 64
2013
Q3
$624K Buy
13,558
+366
+3% +$16.7K 0.1% 238
2013
Q2
$557K Buy
+13,192
New +$549K 0.09% 242

Other funds holding PJP

WFG Advisors's PJP Position: Q2 2017 in Review

WFG Advisors increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.14% in Q2 2017, buying an estimated $60 and bringing the position to 734 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #717.

WFG Advisors first reported a position in PJP in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.68M in Q3 2014. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

  • WFG Advisors held 734 shares of Invesco Pharmaceuticals ETF worth $46K as of Q2 2017.
  • WFG Advisors bought 1 Invesco Pharmaceuticals ETF share in Q2 2017, an estimated $60.
  • Invesco Pharmaceuticals ETF made up 0.01% of WFG Advisors's portfolio in Q2 2017, its #717 holding.
  • WFG Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 17 quarters since.
  • WFG Advisors's Invesco Pharmaceuticals ETF position peaked at $2.68M in Q3 2014.
  • 99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.